Drawing for ISA PHARMACEUTICALS

USPTO serial 86288618

ISA PHARMACEUTICALS

Reviewed by CopyMark Law Group

Reg. 4767213Status 710
Filing date
Status date
Registration date
Jul 7, 2015
Examiner
CANTONE, KERI H
Law office
TMEG LAW OFFICE 104

What this means

Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active. Evaluate filing a new application if you still use the mark, or petition if cancellation was erroneous. Consult counsel on remaining common-law rights.

Status 710: Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active.

Need help with ISA PHARMACEUTICALS?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Peter Nussbaum

Peter Nussbaum Chiesa Shahinian & Giantomasi Pc105 Eisenhower ParkwayRoseland, NJ 07068UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
005[ Pharmaceutical and medicinal preparations for the treatment of viral infections, cancer and pre-cancerous disorders; active pharmaceutical substances based on synthetic long peptides which may be modified to improve the immune response and may be combined with other pharmaceutical products for the treatment of viral infections, cancer and pre-cancerous disorders; immune response adjuvants for medical purposes; pharmaceutical compounds for treating viral infections, cancer and pre-cancerous disorders by means of immune system modulation ]SECTION 8 - CANCELLED—
042Scientific and technological services and research and design relating thereto in the biotechnological, chemical and pharmaceutical field and in the field of immunotherapy; industrial analysis, namely, analysis of the design, manufacturing and development of immunotherapy pharmaceuticals; research services in the field of pharmaceuticals; scientific research and development services in the biotechnological, chemical and pharmaceutical field and in the field of immunotherapySECTION 8 - CANCELLED—
044Medical services in the biotechnological and pharmaceutical field and in the field of immunotherapySECTION 8 - CANCELLED—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Jan 23, 2026CAEXCANCELLED SEC. 8 (10-YR)/EXPIRED SECTION 9—
Jul 7, 2024REM2COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED—
Jan 26, 2023TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Jan 26, 2023ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jan 26, 2023REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Jun 17, 2022NA85NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED—
Jun 17, 2022C15AREGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.—
Jun 17, 2022APRECASE ASSIGNED TO POST REGISTRATION PARALEGAL—
Jan 7, 2022E815TEAS SECTION 8 & 15 RECEIVED—
Jul 7, 2020REM1COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED—
Jul 7, 2015R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
May 26, 2015ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
May 26, 2015REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Apr 21, 2015NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Apr 21, 2015PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Apr 1, 2015NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Mar 16, 2015PREVLAW OFFICE PUBLICATION REVIEW COMPLETED—
Mar 9, 2015CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Mar 9, 2015XAECEXAMINER'S AMENDMENT ENTERED—
Mar 9, 2015GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Mar 9, 2015GNEAEXAMINERS AMENDMENT E-MAILED—
Mar 9, 2015CNEAEXAMINERS AMENDMENT -WRITTEN—
Sep 9, 2014GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Sep 9, 2014GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Sep 9, 2014CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Sep 8, 2014DOCKASSIGNED TO EXAMINER—
Jun 30, 2014AMPXPRELIMINARY/VOLUNTARY AMENDMENT - ENTERED—
Jun 25, 2014ALIEASSIGNED TO LIE—
Jun 12, 2014PARITEAS VOLUNTARY AMENDMENT RECEIVED—
Jun 4, 2014NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
May 26, 2014NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance